Effects of dietary stearidonic acid on biomarkers of lipid metabolism

Journal of Nutrition

Volumn 142, Issue 3, 2012, Pages

  Whelan, Jay ^a,b   Gouffon, Julia ^a   Zhao, Yi ^b  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEARIDONIC ACID; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DOWN REGULATION; EXPERIMENTAL PIG; GENE EXPRESSION; LIPID METABOLISM; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BIOLOGICAL MARKERS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HUMANS; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; THERAPEUTIC EQUIVALENCY;

GLYCINE MAX; SUIDAE;

EID: 84863230347     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.149138     Document Type: Article

References (33)

1. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84:5-17.
2. Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83:S1505-19.
3. Hall MN, Campos H, Li H, Sesso HD, Stampfer MJ, Willett WC, Ma J. Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16:314-21.
4. Fernandez E, Chatenoud L, La VC, Negri E, Franceschi S. Fish consumption and cancer risk. Am J Clin Nutr. 1999;70:85-90.
5. Whelan J, Jahns L, Kavanagh K. Docosahexaenoic acid: measurements in food and dietary exposure. Prostaglandins Leukot Essent Fatty Acids. 2009;81:133-6.
6. Harris WS. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res. 2007;55:217-23.
7. Institute of Medicine. Dietary reference intakes: the essential guide to nutrient requirements. The National Academies Press: Washington, DC; 2006.
8. Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA, Millward DJ. Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res. 2005;46:269-80.
9. James MJ, Ursin VM, Cleland LG. Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr. 2003;77:1140-5.
10. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83: S1467-76.
11. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23:e20-30.
12. McIntyre PB, Jones LE, Flecker AS, Vanni MJ. Fish extinctions alter nutrient recycling in tropical freshwaters. Proc Natl Acad Sci USA. 2007;104:4461-6.
13. Taylor BW, Flecker AS, Hall RO Jr. Loss of a harvested fish species disrupts carbon flow in a diverse tropical river. Science. 2006;313: 833-6.
14. Whelan J. Dietary stearidonic acid is a long chain (n-3) polyunsaturated fatty acid with potential health benefits. J Nutr. 2009;139:5-10.
15. Harris WS. The omega-3 index as a risk factor for coronary heart disease. Am J Clin Nutr. 2008;87:S1997-2002.
16. Lemke SL, Vicini JL, Su H, Goldstein DA, Nemeth MA, Krul ES, Harris WS. Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety. Am J Clin Nutr. 2010;92:766-75.
17. Eckert H, La VB, Schweiger BJ, Kinney AJ, Cahoon EB, Clemente T. Co-expression of the borage Delta 6 desaturase and the Arabidopsis Delta 15 desaturase results in high accumulation of stearidonic acid in the seeds of transgenic soybean. Planta. 2006;224:1050-7.
18. Ursin VM. Modification of plant lipids for human health: development of functional land-based omega-3 fatty acids. J Nutr. 2003;133:4271-4.
19. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189:19-30.
20. Hartweg J, Farmer AJ, Perera R, Holman RR, Neil HA. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia. 2007;50:1593-602.
21. Harris WS, Lemke SL, Hansen SN, Goldstein DA, Dirienzo MA, Su H, Nemeth MA, Taylor ML, Ahmed G, George C. Stearidonic acidenriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker. Lipids. 2008;43:805-11.
22. Rucker R, Storms D. Interspecies comparisons of micronutrient requirements: metabolic vs. absolute body size. J Nutr. 2002;132:2999-3000.
23. Weldon KA, Whelan J. Allometric scaling of dietary linoleic acid on changes in tissue arachidonic acid using human equivalent diets in mice. Nutr Metab (Lond). 2011;8:43.
24. Nakamura MT, Nara TY. Gene regulation of mammalian desaturases. Biochem Soc Trans. 2002;30:1076-9.
25. Warensjö E, Rosell M, Hellenius ML, Vessby B, De FU, Riserus U. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance. Lipids Health Dis. 2009;8:37.
26. Précourt LP, Amre D, Denis MC, Lavoie JC, Delvin E, Seidman E, Levy E. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis. 2011;214:20-36.
27. Labrecque B, Beaudry D, Mayhue M, Halle C, Bordignon V, Murphy BD, Palin MF. Molecular characterization and expression analysis of the porcine paraoxonase 3 (PON3) gene. Gene. 2009;443:110-20.
28. Shih DM, Xia YR, Wang XP, Wang SS, Bourquard N, Fogelman AM, Lusis AJ, Reddy ST. Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice. Circ Res. 2007;100:1200-7.
29. Genest J. C-reactive protein: risk factor, biomarker and/or therapeutic target? Can J Cardiol. 2010; 26 Suppl A:S41-4.
30. Kris-Etherton PM, Harris WS, Appel LJ. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23:151-2.
31. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr. 2011;93:950-62.
32. McKenney JM, Sica D. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy. 2007;27:715-28.
33. Skulas-Ray AC, Kris-Etherton PM, Harris WS, Vanden Heuvel JP, Wagner PR, West SG. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr. 2011;93:243-52.